
TZP GLP2 — 10 · 10 mg
A dual GIP/GLP-1 agonist, once weekly. Approved as Mounjaro and Zepbound — this is one of the most thoroughly studied weight-loss compounds in existence.
Includes 10× sterile insulin syringes + 1 vial of bacteriostatic water, free with your order.
Complete your kit
For research and educational use only. Not for human or veterinary consumption.
- Strong appetite suppression with a smoother feel than semaglutide — the GIP arm appears to blunt nausea
- Food noise reduction, same as retatrutide
- Earlier satiety, smaller portions feel sufficient
- Substantial fat loss — in SURMOUNT-1, about 17.8% placebo-adjusted loss at 15 mg over 72 weeks
- Better blood sugar control — this is its original approved indication
- Improved sleep apnoea — Zepbound holds an approval for this
It does not outperform retatrutide. In the SURMOUNT-5 head-to-head it beat semaglutide (−20.2% vs −13.7%), but retatrutide's trials run higher still.
It does not hold weight off after you stop. SURMOUNT-MAINTAIN documented the regain.
It does not build or protect muscle.
Common: nausea, diarrhoea, vomiting, constipation — dose-dependent, concentrated during escalation, usually settling within a week of each step. Less common: injection site reactions, fatigue, hair shedding at 3–4 months, gallbladder symptoms. Stop and see a doctor: severe abdominal pain radiating to the back; persistent vomiting.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
10 mg vial + 1 mL bacteriostatic water = 10 mg/mL
| Dose | Volume | Units (U-100) |
|---|---|---|
| 2.5 mg | 0.25 mL | 25 |
| 5 mg | 0.50 mL | 50 |
⚠️ Use 1 mL, not 2. At 2 mL a 5 mg dose would need 100 clicks — over the pen limit.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
Once weekly, subcutaneous.
| Weeks | Dose | Units (U-100) |
|---|---|---|
| 1–4 | 2.5 mg | 25 |
| 5+ | 5 mg | 50 |
The approved label continues to 7.5, 10, 12.5 and 15 mg at four-week intervals. Maintenance in trials was 5, 10 or 15 mg. One 10 mg vial covers four weeks at 2.5 mg then finishes during week 5 at 5 mg — plan two vials for an 8-week run.
Cycle: 20 weeks to reach maintenance in trials; loss continued to 72 weeks.
- 1× TZP GLP2 — 10 · 10 mg
- 10× sterile insulin syringes (free)
- 1× bacteriostatic water vial (free)
- Compound Guide — printed, included free
Approved medicine with an enormous trial base. What we supply is research-grade material, not the branded pharmaceutical.
Athletes: tirzepatide is on the WADA Monitoring Program — not prohibited.
Every peptide batch we sell is tested by Janoshik Analytical, an independent laboratory. Every vial carries an internal AVERON batch code identifying the lot received; each lot is linked to its published Janoshik report. The report carries the manufacturer's submission/task number, not the AVERON code. Ask us or our driver which report covers your code and open it on the laboratory's own website before paying. In our own-driver zone, the team shows you the vial and the report for that batch before payment.
A lab report handed to you by a seller and a lab report you can verify yourself are not the same thing. That's why we publish ours.
View COA on JanoshikMore in Body Composition


R3TA GLP3 — 20
Extended-supply vial for longer research protocols.

SMG GLP1 — 10
Once-weekly GLP-1 with the deepest trial record in its class







